0001493152-24-010571.txt : 20240319
0001493152-24-010571.hdr.sgml : 20240319
20240319214903
ACCESSION NUMBER: 0001493152-24-010571
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240317
FILED AS OF DATE: 20240319
DATE AS OF CHANGE: 20240319
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Barr Jason Michael
CENTRAL INDEX KEY: 0001645550
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-21617
FILM NUMBER: 24766183
MAIL ADDRESS:
STREET 1: 902 BROADWAY, 15TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10010
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ProPhase Labs, Inc.
CENTRAL INDEX KEY: 0000868278
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 232577138
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 711 STEWART AVE, SUITE 200
STREET 2: GARDEN CITY
CITY: NEW YORK
STATE: NY
ZIP: 11530
BUSINESS PHONE: (215) 345-0919
MAIL ADDRESS:
STREET 1: 711 STEWART AVE, SUITE 200
STREET 2: GARDEN CITY
CITY: NEW YORK
STATE: NY
ZIP: 11530
FORMER COMPANY:
FORMER CONFORMED NAME: QUIGLEY CORP
DATE OF NAME CHANGE: 19930328
4
1
ownership.xml
X0508
4
2024-03-17
0
0000868278
ProPhase Labs, Inc.
PRPH
0001645550
Barr Jason Michael
711 STEWART AVENUE,
SUITE 200
GARDEN CITY,
NY
11530
1
0
0
0
0
Option (right to buy)
6.00
2024-03-17
4
A
0
70000
0
A
2031-03-17
Common Stock
70000
70000
D
Options shall vest and become exercisable in four equal installments, with 25% of such award vesting and becoming exercisable on each of September 30, 2024, December 31, 2024, March 31, 2025 and June 30, 2025 provided the recipient continues to serve as a non-employee director of the Issuer on each such vesting date.
/s/ Jason Barr
2024-03-19